Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 6.37 M6.81 M15.23 M-2.9 M 25.5 M Research & development ———— — Operating income -19.5 M16.99 M10.09 M27.99 M 35.57 M Non-Operating Income, Total -618 K211 K279 K69 K -59 K Interest expense, net of interest capitalized 11.88 M11.27 M10.49 M10.55 M 44.19 M Non-Operating Income, excl. Interest Expenses -12.5 M-11.06 M-10.21 M-10.48 M -44.25 M Unusual income/expense ———— — Pretax income -16.51 M5.03 M-1.95 M7.75 M -5.68 M Equity in earnings ———— — Taxes -4.92 M1.16 M-1.04 M2.41 M -2.39 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -11.59 M3.87 M-907 K5.33 M -3.29 M Discontinued operations ———— — Net income -11.59 M3.87 M-907 K5.33 M -3.29 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -11.59 M3.87 M-907 K5.33 M -3.29 M Basic earnings per share (Basic EPS) ——-0.050.29 — Diluted earnings per share (Diluted EPS) ——-0.050.29 — Average basic shares outstanding ——18.52 M18.53 M — Diluted shares outstanding ——18.52 M18.53 M — EBITDA -31.64 M4.96 M-1.44 M15.9 M -12.21 M EBIT -31.65 M5 M-1.36 M16.03 M -11.97 M Cost of revenue 17.62 M1.07 M1.54 M1.22 M 21.44 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 14 K-45 K-80 K-130 K -241 K